Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Stada Breaks The €4bn Barrier Ahead Of Potential IPO – Sooner Or Later?
German Generics Giant Says It Is ‘Growing Ahead Of The Market’
Mar 18 2025
•
By
Dave Wallace
Stada says it is outperforming the market
(Shutterstock)
More from Strategy
More from Earnings